ARTA
CPRX

A.R.T. Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

A.R.T. Advisors’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-51,024
Closed -$196K – 1476
2019
Q2 		$196K Buy
51,024
+39,400
+339% +$170K 0.01% 1113
2019
Q1 		$59K Sell
11,624
-77,657
-87% -$228K ﹤0.01% 1206
2018
Q4 		$171K Buy
89,281
+67,355
+307% +$193K 0.01% 1095
2018
Q3 		$82K Buy
+21,926
New +$68.7K ﹤0.01% 1291
2018
Q2 		– Sell
-109,954
Closed -$262K – 1475
2018
Q1 		$262K Sell
109,954
-65,610
-37% -$218K 0.01% 1180
2017
Q4 		$686K Buy
175,564
+98,157
+127% +$324K 0.03% 772
2017
Q3 		$195K Buy
77,407
+65,000
+524% +$178K 0.01% 1141
2017
Q2 		$34K Sell
12,407
-38,800
-76% -$81K ﹤0.01% 1326
2017
Q1 		$99K Sell
51,207
-12,093
-19% -$15.4K ﹤0.01% 1270
2016
Q4 		$66K Buy
+63,300
New +$72.3K ﹤0.01% 1195
2016
Q3 		– Sell
-126,289
Closed -$89K – 741
2016
Q2 		$89K Sell
126,289
-99,239
-44% -$79.9K ﹤0.01% 1218
2016
Q1 		$263K Buy
225,528
+191,800
+569% +$298K 0.01% 1083
2015
Q4 		$82K Buy
+33,728
New +$96.6K ﹤0.01% 1347
2015
Q2 		– Sell
-92,100
Closed -$398K – 1509
2015
Q1 		$398K Buy
92,100
+56,058
+156% +$202K 0.01% 1003
2014
Q4 		$107K Sell
36,042
-26,039
-42% -$71.5K ﹤0.01% 1301
2014
Q3 		$206K Buy
+62,081
New +$162K 0.01% 1087

Other funds holding CPRX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

A.R.T. Advisors's CPRX Position: Q3 2019 in Review

A.R.T. Advisors sold out of Catalyst Pharmaceutical (CPRX) in Q3 2019, closing a stake of 51,024 shares — an estimated $196K sold.

A.R.T. Advisors first reported a position in CPRX in Q3 2014 and held it in 16 quarters. The position peaked at $686K in Q4 2017. 117 funds tracked by Wall St. Rank hold CPRX as of Q3 2019.

  • A.R.T. Advisors reported no remaining Catalyst Pharmaceutical position as of Q3 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 51,024 Catalyst Pharmaceutical shares in Q3 2019, an estimated $196K.
  • A.R.T. Advisors first reported a position in Catalyst Pharmaceutical in Q3 2014 and held it in 16 quarters.
  • A.R.T. Advisors's Catalyst Pharmaceutical position peaked at $686K in Q4 2017.
  • 117 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.